Scientific progress begins with curiosity, dedication, and a commitment to improving lives. This year, The Myositis Association (TMA) is proud to recognize Conrad “Chris” Weihl, MD, PhD, as the recipient…
Continue Reading
FDA Approves First Oral Treatment for Adults with Dermatomyositis
If you’ve been hearing cheers from TMA today, there’s a good reason. We are absolutely thrilled to share news that many patients, care partners, clinicians, and researchers have been working…
Continue Reading
Hospital for Special Surgery Receives TMA’s 2026 Heroes in Healthcare Award
Every year, The Myositis Association (TMA) honors individuals and organizations whose dedication, innovation, and compassion make a lasting difference in the lives of those affected by myositis. As part of…
Continue Reading
Gratitude and Giving Back
Mike Foley knows what it means to live with uncertainty. Diagnosed with inclusion body myositis (IBM) in 2013 after years of unexplained symptoms and an initial misdiagnosis of ALS, Mike…
Continue Reading
New Hope on the Horizon
Promising Trial News from argenx and Abcuro The myositis community recently received encouraging news from two companies developing treatments for different forms of myositis. While much work remains before these…
Continue Reading